Fairfield, Bush & Co’s Allergan Inc AGN Stock Holding History

Fairfield, Bush & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,939	Closed	-$625K	–	182
2014 Q4	$625K	Hold	2,939	–	–	0.18%	100
2014 Q3	$524K	Hold	2,939	–	–	0.15%	109
2014 Q2	$497K	Sell	2,939 -275	-9%	-$42.8K	0.15%	108
2014 Q1	$399K	Sell	3,214 -150	-4%	-$18.3K	0.19%	73
2013 Q4	$374K	Hold	3,364	–	–	0.17%	80
2013 Q3	$304K	Hold	3,364	–	–	0.09%	124
2013 Q2	$283K	Buy	+3,364	New	+$349K	0.14%	112

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Fairfield, Bush & Co's AGN Position: Q1 2015 in Review

Fairfield, Bush & Co sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,939 shares — an estimated $625K sold.

Fairfield, Bush & Co first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $625K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Fairfield, Bush & Co reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Fairfield, Bush & Co sold 2,939 Allergan Inc shares in Q1 2015, an estimated $625K.
Fairfield, Bush & Co first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Fairfield, Bush & Co's Allergan Inc position peaked at $625K in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Fairfield, Bush & Co's 13F filing for Q1 2015, filed 15 May 2015.